您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [港股财报]:健康之路2024年度报告 - 发现报告

健康之路2024年度报告

2025-04-23 港股财报 徐雨泽
报告封面

(Incorporated in the Cayman Islands with limited liability) 股份代號Stock Code:2587 Annual Report2024年 度 報 告 CONTENTS目 錄 Corporate Information2Chairman’s Statement5Management Discussion and Analysis7Directors and Senior Management Profile21Corporate Governance Report34Environmental, Social and Governance Report53Report of the Directors111Independent Auditor’s Report151Consolidated Statement of Profit or Loss andOther Comprehensive Income158Consolidated Statement of Financial Position160Consolidated Statement of Changes in Equity162Consolidated Statement of Cash Flows163Notes to the Consolidated Financial Statements165Summary of Financial Information264 CORPORATE INFORMATION BOARD OF DIRECTORS Executive Directors Mr. Zhang Wanneng(Chairman and chief executive officer)Mr. Chen Jing Non-executive Directors Mr. Chen YongMr. Zhang Xiangming Independent Non-executive Directors Lu Tao Mr. Xu JingDr. Lu TaoMs. Deng Xiaolan AUDIT COMMITTEE Mr. Xu Jing(Chairperson)Mr. Zhang XiangmingMs. Deng Xiaolan REMUNERATION COMMITTEE Lu Tao Dr. Lu Tao(Chairperson)Mr. Zhang XiangmingMs. Deng Xiaolan NOMINATION COMMITTEE Lu Tao Dr. Lu Tao(Chairperson)Mr. Zhang XiangmingMs. Deng Xiaolan JOINT COMPANY SECRETARIES 20253282025328 Mr. Chen Zhoufeng (Appointed on 28 March 2025)Mr. Li Guomin (Resigned on 28 March 2025)Mr. Tam Chun Wai Edwin AUTHORISED REPRESENTATIVES Mr. Zhang WannengMr. Tam Chun Wai Edwin CORPORATE INFORMATION COMPLIANCE ADVISOR 83 Giraffe Capital Limited3rd Floor, 8 Wyndham StreetCentral Hong Kong AUDITOR KPMG Certified Public Accountants and Public Interest Entity Auditorregistered in accordance with the Accounting and FinancialReporting Council Ordinance8th Floor Prince’s Building10 Chater RoadCentral Hong Kong 108 LEGAL ADVISOR AS TO HONG KONG LAWS One Island South1002 & 1207 Edwin Kwok & Co Units 1002 & 1207One Island South2 Heung Yip RoadWong Chuk HangHong Kong REGISTERED OFFICE P.O. Box 31119 Grand PavilionHibiscus Way, 802 West Bay Road,Grand Cayman KY1-1205Cayman Islands P.O. Box 31119 Grand PavilionHibiscus Way, 802 West Bay Road,Grand Cayman KY1-1205Cayman Islands PRINCIPAL PLACE OF BUSINESS IN HONGKONG 1494 4th Floor, Wah Yuen Building149 Queen’s Road Central, Central, Hong Kong HEADQUARTERS AND PRINCIPAL PLACE OFBUSINESS IN CHINA 89F322 22nd Floor, No. 3 BuildingF Zone, Fuzhou Software Park89 Software AvenueGulou DistrictFuzhou, Fujian PRC CORPORATE INFORMATION PRINCIPAL SHARE REGISTRAR Vistra (Cayman) LimitedP.O. Box 31119 Grand PavilionHibiscus Way, 802 West Bay Road,Grand Cayman KY1-1205Cayman Islands Vistra (Cayman) LimitedP.O. Box 31119 Grand PavilionHibiscus Way, 802 West Bay Road,Grand Cayman KY1-1205Cayman Islands HONG KONG SHARE REGISTRAR 183171712-1716 Computershare Hong Kong Investor Services LimitedShops 1712-1716, 17th Floor, Hopewell Centre183 Queen’s Road EastWan ChaiHong Kong MAIN PRINCIPAL BANKS 3161 China Merchants Bank Co., Ltd. Fuzhou Branch1st Floor, Zhaoyin BuildingNo. 316 Jiangbinzhong AvenueTaijiang DistrictFuzhou, Fujian PRC 1581 Industrial Bank Co., Ltd. Fuzhou Global Branch1st Floor, Global Plaza158 Wusi RoadGulou DistrictFuzhou, Fujian PRC 45 CMB Wing Lung Bank Limited45 Des Voeux RoadCentral Hong Kong www.jkzlkj.cn COMPANY’S WEBSITE 2587 STOCK CODE 2587 CHAIRMAN’S STATEMENT Dear Shareholders, 20241231 On behalf of the board (the “Board”) of the directors (the“Directors”) of HealthyWay Inc. (the “Company”, together withits subsidiaries, the “Group”), I am pleased to present the annualreport of the Company for the year ended 31 December 2024 (the“Year”). This is our first annual report since our listing on 30 December2024 (the “Listing Date”). The successful listing (“Listing”) ofour shares on the Main Board of The Stock Exchange of HongKong Limited (the “Stock Exchange”) marked a new chapter ofthe Group and has opened up new opportunities for our growth. 20241230 As a pioneer of digital health and medical services in China, wehave participated in the major digital transformations of China’shealth and wellness industry over the last two decades. Weare committed to guide and support patients at each stage oftheir health and disease management, from initial consultationto claims processing, and from disease and medical expenseinformation to treatment options and medicine purchase. We alsostrive to reduce the trouble and inconvenience of people seekinghealth and medical resources throughout their experience from in-hospital visits to out-of-hospital healthcare fulfillment. Last year, our business operations continued to grow. The numberof registered individual users on our platform increased by 10.5%and the number of our registered physicians increased by 58.8%.The number of hospitals connected to our platform also increasedby 59.7% in 2024. 10.5%58.8%202459.7% 202420241002024 We continued to receive awards and accolades from variousorganizations and authorities. We were named by the Officeof the Leading Group f